Trending News
News
News
Gene Logic Completes Sale of Genomics Assets to Ocimum Biosolutions
Gene Logic Inc. renamed Ore Pharmaceuticals Inc.; also commitment to drug repositioning and development business reaffirmed.
News
Applied Biosystems and METTLER TOLEDO Introduce Solution to Simplify the Flow of Information in Life Science and Chemistry Laboratories
Integration of Laboratory Information Management Systems with instrument software reduces laboratory time and costs.
News
Ambrx Announces Drug Discovery Alliance with Eli Lilly and Company
Ambrx to collaborate with Lilly to discover protein and antibody drug candidates targeting multiple therapeutic areas using Ambrx's ReCODE™ platform.
News
Eurogentec Expands Global GMP Oligonucleotide Manufacturing Facilities
Eurogentec has announced that it is making a significant capital investment to expand its current GMP oligonucleotide manufacturing facility in Belgium.
News
Specialists at Moores UCSD Cancer Center Evaluate New Option for Treating Advanced Melanoma
San Diego-area residents may be eligible to participate in a clinical research study.
News
Thermo Fisher Scientific Appoints Puerto Rico Partner Quality Instruments Solutions to Support Informatics Sales
The new distribution agreement allows QIS to support sales activities in Puerto Rico and the wider Caribbean for the complete Thermo Scientific informatics product range.
News
PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study
PARI's eFlow was optimized and used to deliver Alnylam's ALN-RSV01 in a Phase I human clinical trial for the treatment of respiratory syncytial virus infection.
News
BioWa and Lonza Collaborates to Generate Optimized Production Platform for Potent Antibodies
The parties intend to make the POTELLIGENT® CHOK1SV cell line available in combination with Lonza’s GS Gene Expression System™.
News
CECE2007 Meeting Report
The fourth International Workshop, CECE 2007, was held in Brno, the Czech Republic on November 15th and 16th. The multidisciplinary meeting, covering modern bioanalytical technology and applications, was organized by the Institute of Analytical Chemistry in Brno.
News
Discovery of Novel Anti-tumor Antimitotic Agents That Also Reverse Tumor Resistance
Scientists at Duquesne University and the Medical University of South Carolina report in the on line version of the Journal of Medicinal Chemistry (50, 3290, 2007) on novel compounds with potent anti-tumor activity, which are also active on cancer cells resistant to other anti-tumor agents.
Advertisement